Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Russell Middaugh

Showing results (261-270 of 271) with videos related to

Pageof 28
Sort By:
Journal of Pharmaceutical Sciences|July 27, 2017
Comparative Characterization of Crofelemer Samples Using Data Mining and Machine Learning Approaches With Analytical Stability Data SetsMaulik K Nariya, Jae Hyun Kim, Jian Xiong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 11, 2018
Glatiramer acetate persists at the injection site and draining lymph nodes via electrostatically-induced aggregationJimmy Y Song, Nicholas R Larson, Sharadvi Thati, et al.
Journal of Pharmaceutical Sciences|October 25, 2016
An S116R Phosphorylation Site Mutation in Human Fibroblast Growth Factor-1 Differentially Affects Mitogenic and Glucose-Lowering ActivitiesXue Xia, Ozan S Kumru, Sachiko I Blaber, et al.
ACS Applied Bio Materials|January 12, 2022
Amino/Amido Conjugates Form to Nanoscale Cobalt Physiometacomposite (PMC) Materials Functionally Delivering Nucleic Acid Therapeutic to Nucleus Enhancing Anticancer Activity via Ras-Targeted Protein InterferenceRobert K DeLong, John Dean, Garry Glaspell, et al.
Journal of Pharmaceutical Sciences|January 13, 2015
Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvantsKimberly J Hassett, David J Vance, Nishant K Jain, et al.
Human Vaccines & Immunotherapeutics|August 9, 2013
Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccineVidyashankara Iyer, Lei Hu, Carole E Schanté, et al.
Infection and Immunity|November 5, 2014
Impact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella speciesXiaotong Chen, Shyamal P Choudhari, Francisco J Martinez-Becerra, et al.
Journal of Pharmaceutical Sciences|August 16, 2008
Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product qualityJohn F Carpenter, Theodore W Randolph, Wim Jiskoot, et al.
Journal of Pharmaceutical Sciences|August 23, 2011
Biophysical characterization and conformational stability of Ebola and Marburg virus-like particlesLei Hu, Jared M Trefethen, Yuhong Zeng, et al.
Vaccine|December 14, 2020
Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonistsAthina Zacharia, Erin Harberts, Sarah M Valencia, et al.
Pageof 28

Showing results (261-270 of 271) with videos related to

Sort By:
Pageof 28
Journal of Pharmaceutical Sciences|July 27, 2017
Comparative Characterization of Crofelemer Samples Using Data Mining and Machine Learning Approaches With Analytical Stability Data SetsMaulik K Nariya, Jae Hyun Kim, Jian Xiong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 11, 2018
Glatiramer acetate persists at the injection site and draining lymph nodes via electrostatically-induced aggregationJimmy Y Song, Nicholas R Larson, Sharadvi Thati, et al.
Journal of Pharmaceutical Sciences|October 25, 2016
An S116R Phosphorylation Site Mutation in Human Fibroblast Growth Factor-1 Differentially Affects Mitogenic and Glucose-Lowering ActivitiesXue Xia, Ozan S Kumru, Sachiko I Blaber, et al.
ACS Applied Bio Materials|January 12, 2022
Amino/Amido Conjugates Form to Nanoscale Cobalt Physiometacomposite (PMC) Materials Functionally Delivering Nucleic Acid Therapeutic to Nucleus Enhancing Anticancer Activity via Ras-Targeted Protein InterferenceRobert K DeLong, John Dean, Garry Glaspell, et al.
Journal of Pharmaceutical Sciences|January 13, 2015
Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvantsKimberly J Hassett, David J Vance, Nishant K Jain, et al.
Human Vaccines & Immunotherapeutics|August 9, 2013
Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccineVidyashankara Iyer, Lei Hu, Carole E Schanté, et al.
Infection and Immunity|November 5, 2014
Impact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella speciesXiaotong Chen, Shyamal P Choudhari, Francisco J Martinez-Becerra, et al.
Journal of Pharmaceutical Sciences|August 16, 2008
Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product qualityJohn F Carpenter, Theodore W Randolph, Wim Jiskoot, et al.
Journal of Pharmaceutical Sciences|August 23, 2011
Biophysical characterization and conformational stability of Ebola and Marburg virus-like particlesLei Hu, Jared M Trefethen, Yuhong Zeng, et al.
Vaccine|December 14, 2020
Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonistsAthina Zacharia, Erin Harberts, Sarah M Valencia, et al.
Pageof 28